FGF23 and chronic kidney disease: Whilst this calcium release from the bone is accompanied by phosphate release as well, FGF-23 secreted by osteocytes works to increase phosphaturia in the distal tubule by upregulating sodium-phosphate transporters to prevent hyperphosphatemia [23], at least in healthy individuals and those with early stages of CKD [11].